ELVN logo

Enliven Therapeutics, Inc. (ELVN) Working capital

annual working capital:

$302.21M+$61.95M(+25.79%)
December 31, 2024

Summary

  • As of today (August 22, 2025), ELVN annual working capital is $302.21 million, with the most recent change of +$61.95 million (+25.79%) on December 31, 2024.
  • During the last 3 years, ELVN annual working capital has risen by +$197.29 million (+188.05%).
  • ELVN annual working capital is now at all-time high.

Performance

ELVN Working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVNbalance sheet metrics

quarterly working capital:

$480.41M+$200.06M(+71.36%)
June 30, 2025

Summary

  • As of today (August 22, 2025), ELVN quarterly working capital is $480.41 million, with the most recent change of +$200.06 million (+71.36%) on June 30, 2025.
  • Over the past year, ELVN quarterly working capital has increased by +$184.39 million (+62.29%).
  • ELVN quarterly working capital is now at all-time high.

Performance

ELVN quarterly working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVNbalance sheet metrics

Working capital Formula

Working Capital = Current Assets − Current Liabilities

ELVN Working capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+25.8%+62.3%
3 y3 years+188.1%+688.1%
5 y5 years+1043.6%+354.3%

ELVN Working capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+244.2%at high+738.6%
5 y5-yearat high+1043.6%at high+738.6%
alltimeall timeat high+5045.8%at high+738.6%

ELVN Working capital History

DateAnnualQuarterly
Jun 2025
-
$480.41M(+71.4%)
Mar 2025
-
$280.35M(-7.2%)
Dec 2024
$302.21M(+25.8%)
$302.21M(+7.9%)
Sep 2024
-
$279.97M(-5.4%)
Jun 2024
-
$296.02M(-5.2%)
Mar 2024
-
$312.17M(+29.9%)
Dec 2023
$240.26M(+173.6%)
$240.26M(-6.3%)
Sep 2023
-
$256.53M(-6.4%)
Jun 2023
-
$274.03M(-4.5%)
Mar 2023
-
$287.06M(+226.9%)
Dec 2022
$87.81M
$87.81M(+53.3%)
Sep 2022
-
$57.29M(-6.0%)
Jun 2022
-
$60.95M(-14.5%)
DateAnnualQuarterly
Mar 2022
-
$71.31M(-16.6%)
Dec 2021
$104.92M(+24.7%)
-
Dec 2021
-
$85.49M(-13.5%)
Sep 2021
-
$98.81M(+53.5%)
Jun 2021
-
$64.38M(-14.0%)
Mar 2021
-
$74.86M(-11.1%)
Dec 2020
$84.16M(+218.5%)
$84.16M(-10.9%)
Sep 2020
-
$94.40M(-10.7%)
Jun 2020
-
$105.75M(+0.8%)
Mar 2020
-
$104.87M
Dec 2019
$26.43M(+350.0%)
-
Dec 2018
$5.87M(-37.5%)
-
Dec 2017
$9.40M
-

FAQ

  • What is Enliven Therapeutics, Inc. annual working capital?
  • What is the all time high annual working capital for Enliven Therapeutics, Inc.?
  • What is Enliven Therapeutics, Inc. annual working capital year-on-year change?
  • What is Enliven Therapeutics, Inc. quarterly working capital?
  • What is the all time high quarterly working capital for Enliven Therapeutics, Inc.?
  • What is Enliven Therapeutics, Inc. quarterly working capital year-on-year change?

What is Enliven Therapeutics, Inc. annual working capital?

The current annual working capital of ELVN is $302.21M

What is the all time high annual working capital for Enliven Therapeutics, Inc.?

Enliven Therapeutics, Inc. all-time high annual working capital is $302.21M

What is Enliven Therapeutics, Inc. annual working capital year-on-year change?

Over the past year, ELVN annual working capital has changed by +$61.95M (+25.79%)

What is Enliven Therapeutics, Inc. quarterly working capital?

The current quarterly working capital of ELVN is $480.41M

What is the all time high quarterly working capital for Enliven Therapeutics, Inc.?

Enliven Therapeutics, Inc. all-time high quarterly working capital is $480.41M

What is Enliven Therapeutics, Inc. quarterly working capital year-on-year change?

Over the past year, ELVN quarterly working capital has changed by +$184.39M (+62.29%)
On this page